aspartic acid has been researched along with Diabetic Glomerulosclerosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, E; Gohda, T; Ichikawa, S; Koshida, T; Li, Z; Murakoshi, M; Suzuki, Y | 1 |
| Niu, H; Shen, J; Shi, X; Wang, R; Wang, S; Wu, J; Yang, H; Zhang, Y; Zhou, S | 1 |
| Hiraga, K; Ichsan, AM; Ishii, Y; Kato, I; Nakada, S; Okamoto, H; Oya, T; Sasahara, M; Shimada, Y; Suzuki, H; Takasawa, K; Takasawa, S; Tobe, K | 1 |
| Hiraga, K; Kato, I; Kawaguchi, H; Okamoto, H; Oya, T; Sasahara, M; Suzuki, H; Tabuchi, Y; Takasaki, I; Takasawa, S; Tobe, K; Tsuneyama, K; Usui, I | 1 |
| Reismann, P | 1 |
| Fukazawa, Y; Mito, Y; Tajima, Y; Yanai, M | 1 |
| Cai, H; Colagiuri, S; Wang, X; Wilcken, DE | 1 |
7 other study(ies) available for aspartic acid and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice.
Topics: Albuminuria; Animals; Aspartic Acid; Diabetic Nephropathies; Dietary Supplements; Disease Models, Animal; Endothelium; Female; Glomerular Basement Membrane; Humans; Male; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Nitric Oxide Synthase Type III; Oxidative Stress | 2020 |
[Correlation between cognitive impairment and diabetic nephropathy in patients with Type 2 diabetes mellitus].
Topics: Adult; Aspartic Acid; Case-Control Studies; Cerebrum; Choline; Cognition; Cognition Disorders; Creatine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Neuropsychological Tests | 2016 |
A novel model of insulin-dependent diabetes with renal and retinal lesions by transgenic expression of CaMKIIalpha (Thr286Asp) in pancreatic beta-cells.
Topics: Amino Acid Substitution; Animals; Animals, Genetically Modified; Aspartic Acid; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; DNA Primers; Female; Insulin-Secreting Cells; Mice; Mice, Inbred Strains; Threonine | 2008 |
Characterization of diabetic nephropathy in CaM kinase IIalpha (Thr286Asp) transgenic mice.
Topics: Amino Acid Substitution; Animals; Antigens, Differentiation; Aspartic Acid; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Diabetic Nephropathies; Disease Models, Animal; Kidney; Macrophages; Male; Mice; Mice, Transgenic; Oligonucleotide Array Sequence Analysis; Osteopontin; RNA, Messenger; Threonine | 2009 |
[Study of the Toll-like receptor 4 gene polymorphisms in diseases presenting with subclinical and chronic inflammation].
Topics: Alleles; Aspartic Acid; Brain Ischemia; Chronic Disease; Cytokines; Diabetes Complications; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Glycine; Humans; Inflammation; Isoleucine; Periodontitis; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Stroke; Threonine; Toll-Like Receptor 4 | 2011 |
Unusual basal ganglia lesions in a diabetic uraemic patient proven to be demyelination: first pathological observation.
Topics: Aspartic Acid; Basal Ganglia; Basal Ganglia Diseases; Demyelinating Diseases; Diabetic Nephropathies; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Follow-Up Studies; Humans; Japan; Macrophages; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myelinolysis, Central Pontine; Neurologic Examination; Parkinson Disease; Putamen; Shock, Septic; Uremia | 2012 |
A common Glu298-->Asp (894G-->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes.
Topics: Albuminuria; Amino Acid Substitution; Angina Pectoris; Aspartic Acid; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Exons; Genotype; Glutamic Acid; Humans; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peripheral Vascular Diseases; Point Mutation; Risk Factors | 1998 |